Cognetivity Neurosciences
Healthcare Software · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1980 1075 West Georgia St, Vancouver, Br...Phone Number
+44 2030023628Website
www.cognetivity.comRevenue
<$5 MillionStock Symbol
CGNSFIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cognetivity Neurosciences
Cognetivity is a technology company that has created a cognitive testing platform for use in medical, commercial and consumer environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain to support diagnosis of dementia. It has achieved regulatory approval for clinical use in the UK and Europe with future clinical approval anticipated in North America and elsewhere in the world.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cognetivity Neurosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cognetivity Neurosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cognetivity Neurosciences has new funding data
Click to see if Cognetivity Neurosciences had a recent Job posting/layoffs
Product Launch: Get notified when Cognetivity Neurosciences launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cognetivity Neurosciences recently announced quarterly report
Cognetivity Neurosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Cognetivity Neurosciences
Check out if Cognetivity Neurosciences is spiking on competitors!
Recommended Actions
Find VP level buyers at Cognetivity Neurosciences
Find 3 more new buyers
Compare Similar Companies to Cognetivity Neurosciences
Compare insights from companies similar to Cognetivity Neurosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cognetivity Neurosciences
<$5M
1-10
Public
-
2013
N/A
Company Profile Activity
Activity Insights
Cognetivity Neurosciences is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Cognetivity Neurosciences is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Cognetivity Neurosciences.
Cognetivity Neurosciences Tech Stack
A closer look at the technologies used by Cognetivity Neurosciences
Cognetivity Neurosciences News & Media
Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA
Vancouver, British Columbia--(Newsfile Corp. - October 11, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTC Pink: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading artificial intelligence (AI) healthcare technology company is delighted to announce a collaboration with UC Health, one of the leading healthcare systems in the United States, to improve early detection of cognitive impairment in clinical settings in the USA. Centred in Cincinnati, Ohio, UC Health is one of the...Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s
Vancouver, British Columbia--(Newsfile Corp. - October 3, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTC Pink: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading AI healthcare technology company, is delighted to announce a collaboration with the Mediclinic Group ("Mediclinic"), a prominent international private hospital group operating across Europe, the Middle East and Southern Africa. This pivotal partnership will start in the United Arab Emirates and is set to revolutionizeCognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology
Vancouver, British Columbia--(Newsfile Corp. - September 21, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading artificial intelligence (AI) healthcare technology company is delighted to announce a partnership with No Fear Counselling, the leading and rapidly growing Vancouver-based counselling practice with over 150 therapists and a network of 60 locations. This groundbreaking partnership, utilising Cognetivity's AI powered...Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity"), a leading artificial intelligence (AI) healthcare technology company is delighted to announce that it has won a major AI technology award, with the company's CognICA™ platform being recognised in the CogX Awards as the Best AI Product in Healthcare for 2023. CognICA was chosen as the winner in a strong field of contenders
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cognetivity Neurosciences
Sign Up For FreeTo access detailed company insights
Cognetivity is a technology company that has created a cognitive testing platform for use in medical, commercial and consumer environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain to support diagnosis of deme... Read More
